Feasibility of a Peer-Led Asthma and Smoking Prevention Project in Australian Schools with High Indigenous Youth

Abstract

Background: The high global burden of asthma and tobacco smoking among Indigenous people may potentially be reduced by appropriate interventions that target prevention of tobacco smoke uptake and improved asthma management. The latter includes targeted treatment based on airway inflammation. We undertook a feasibility study in two Darwin schools with a high proportion of Indigenous youth to determine the feasibility of an innovative, peer-led, school-based education program called the Asthma and Smoking Prevention Project (ASPP). A subset of children with reported persistent respiratory symptoms were also clinically evaluated to determine the lower airway inflammatory profile and optimize asthma management.; Methods: The ASPP is founded on an evidence-based three-step program and targets improving asthma management and preventing the uptake of tobacco smoking. The program uses a student-centered approach in which senior students (peer leaders) deliver the ASPP to Grade 7 students using activities, videos, and games. Students completed questionnaires related to asthma and smoking at baseline and 3 months after program delivery. Students with respiratory symptoms at 3 months were invited for a comprehensive clinical evaluation and tests including sputum induction.; Results: The ASPP was well received. Of the 203 students involved, 56 (28%) were Indigenous and 70% completed baseline and follow-up questionnaires. Self-reported asthma was high (19%), 10% of students reported smoking and 63% reported exposure to tobacco at home. Of the 22 students who were clinically evaluated, 41% were Indigenous. Clinically important airway inflammation was high; 23% had Fractional Exhaled Nitric Oxide Levels ≥35 ppb, 88% had airway neutrophilia (>15%), and 29% had airway eosinophilia (>2.5%). Optimization of medication and management was required in 59% of students.; Conclusion: Our study has demonstrated the implementation of the ASPP was well received by the schools as well as by the students. The high prevalence of clinically important airway inflammation and suboptimal asthma management highlights the need for a community-based study on persistent respiratory symptoms in adolescents to reduce the burden of chronic lung disease particularly for Indigenous Australians.eCollection. Cited Medium: Print. NLM ISO Abbr: Front Pediatr. PubMed Central ID: PMC5332358. Linked References: J Paediatr Child Health. 2000 Jun;36(3):249-51. (PMID: 10849226); Clin Exp Allergy. 2000 Aug;30(8):1181-7. (PMID: 10931127); BMJ. 2001 Mar 10;322(7286):583-5. (PMID: 11238152); Arch Dis Child. 2002 Apr;86(4):270-5. (PMID: 11919102); Eur Respir J Suppl. 2002 Sep;37:44s-46s. (PMID: 12361363); BMJ. 2004 Mar 27;328(7442):759-62. (PMID: 15044295); Curr Opin Allergy Clin Immunol. 2007 Feb;7(1):102-6. (PMID: 17218819); Thorax. 2007 Dec;62(12):1034-6. (PMID: 18025139); Prog Lipid Res. 2009 Jan;48(1):27-43. (PMID: 19017534); Aust Fam Physician. 2008 Nov;37(11):952-4. (PMID: 19037472); Curr Opin Pulm Med. 2009 Jan;15(1):39-45. (PMID: 19077704); Tob Induc Dis. 2009 Mar 26;5(1):6. (PMID: 19323826); Thorax. 2009 May;64(5):369-70. (PMID: 19401481); Med J Aust. 2009 May 18;190(10):530-1. (PMID: 19450189); Int J Equity Health. 2009 Oct 31;8:37. (PMID: 19878593); Cochrane Database Syst Rev. 2010 May 12;(5):CD006344. (PMID: 20464742); Thorax. 2012 Mar;67(3):199-208. (PMID: 20937641); Am J Respir Crit Care Med. 2011 Sep 1;184(5):602-15. (PMID: 21885636); Pediatrics. 2012 Jan;129(1):e106-12. (PMID: 22157137); Chest. 2012 Oct;142(4):943-950. (PMID: 22459773); Cochrane Database Syst Rev. 2012 Aug 15;(8):CD009325. (PMID: 22895988); BMC Public Health. 2012 Nov 10;12:963. (PMID: 23140529); Allergy. 2013 Mar;68(3):402-6. (PMID: 23347007); Eur Respir J. 2013 Oct;42(4):1012-9. (PMID: 23349447); Pediatrics. 2013 May;131(5):e1576-83. (PMID: 23610200); Cochrane Database Syst Rev. 2013 Apr 30;(4):CD001293. (PMID: 23633306); Paediatr Child Health. 2012 Aug;17(7):376-80. (PMID: 23904781); J Paediatr Child Health. 2014 Apr;50(4):286-90. (PMID: 24372675); Chest. 2014 Jun;145(6):1271-1278. (PMID: 24435356); BMC Public Health. 2014 Dec 17;14:1296. (PMID: 25518992); Allergy Asthma Proc. 2014 Nov-Dec;35(6):454-61. (PMID: 25584912); Int J Environ Res Public Health. 2015 Jan 15;12(1):841-54. (PMID: 25599375); Med J Aust. 2015 Feb 16;202(3):125-6. (PMID: 25669465); Lancet Respir Med. 2015 Mar;3(3):188-9. (PMID: 25773211); PLoS One. 2015 Jun 12;10(6):e0129517. (PMID: 26066058); BMC Public Health. 2015 Jul 13;15:648. (PMID: 26163878); BMC Public Health. 2016 Jan 11;16:21. (PMID: 26754922); Cochrane Database Syst Rev. 2017 Aug 22;8:CD006580. (PMID: 28828760); Eur Respir J. 1988 May;1(5):428-32. (PMID: 3169213); Lancet. 1996 Aug 31;348(9027):567-72. (PMID: 8774568); J Adolesc Health. 1998 Jan;22(1):66-72. (PMID: 9436069); Eur Respir J. 1998 Feb;11(2):462-6. (PMID: 9551755); Eur Respir J. 1998 Apr;11(4):848-53. (PMID: 9623687). Linking ISSN: 22962360. Subset: PubMed not MEDLINE; Date of Electronic Publication: 2017 Mar 02. ; Original Imprints: Publication: Lausanne : Frontiers Media SA, [2013]- <br />